Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

10 Dec, 2018, 13:11 GMT New long-term evidence from large study reinforces value of the Oncotype DX Breast Recurrence Score® test to guide adjuvant chemotherapy treatment, confirming TAILORx conclusions

Long-term outcomes data from a large population-based study1, presented at the 2018 San Antonio Breast Cancer Symposium® (SABCS), further support the ...


10 Dec, 2018, 08:00 GMT As Fever in Children Reaches Peak Levels, Research From Nurofen Reveals the Hidden and Wide-reaching Impact That Loss of Sleep in Children With Pain or Fever Can Have

Fever and pain in children can lead to lost or disrupted sleep, anxiety among the family and days of nursery, school or work missed due to illness1...


07 Dec, 2018, 14:39 GMT Cantargia: Phase I Safety Evaluation Part of CANFOUR Trial of Antibody CAN04 Completed and Phase IIa Part Being Initiated

Cantargia AB (publ) today announces that all patients in the phase I part of the CANFOUR clinical trial have completed the formal safety evaluation...


07 Dec, 2018, 06:00 GMT Pharming Reports Favourable Conclusion from First Investigator-initiated Direct Comparative Real-world Study of Acute Hereditary Angioedema Therapies

Treatment with recombinant therapy RUCONEST® and plasma-derived C1 treatments requires significantly less re-dosing than icatibant (Firazyr®) to...


06 Dec, 2018, 14:00 GMT Fimbrion and GSK Identify Novel, Antibiotic-Sparing Development Candidate for Urinary Tract Infections

Fimbrion Therapeutics, Inc. announced that under its joint research collaboration with GSK, researchers have identified an orally available, small...


06 Dec, 2018, 11:34 GMT Emosis and Accellix Announce Intent to Form a Joint Venture, EmoCellix

EmoCellix will focus on marketing a complete solution for hemostasis cytomolecular diagnostics The French company Emosis and Accellix today announced ...


06 Dec, 2018, 07:00 GMT Berlin Cures' Steering Committee is Assembled to Facilitate the Design and Implementation of Phase 2 Study of BC 007

Swiss drug developer Berlin Cures Holding AG today announced the establishment of a steering committee of renowned cardiologists focused on ensuring...


05 Dec, 2018, 23:00 GMT Daiichi Sankyo Presents Updated Phase 1 Data for U3-1402 in Patients with HER3-Expressing Metastatic Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS)

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that updated efficacy and safety results from the ongoing phase 1/2 study of...


05 Dec, 2018, 10:00 GMT DTRA Commits Additional Funds to MeMed's Innovative Bacterial Versus Viral Test and Point-of-Care Platform

MeMed's contract with DTRA is expanded to include key verification milestones MeMed today announced DTRA's expanded commitment to their point-of-care ...


05 Dec, 2018, 07:00 GMT Moorfields Dubai Performs Complex High-risk Surgery to Bring Maths Professor Back From the Brink of Blindness

Moorfields Eye Hospital Dubai (Moorfields Dubai) has performed a complex and high-risk surgical procedure as a last resort to prevent a patient...


04 Dec, 2018, 11:56 GMT TIGR(R)Matrix shows promising results when used for incisional hernia prevention in septic patients undergoing laparoscopy

Onlay mesh placement of the synthetic and fully resorbable TIGR®Matrix surgical mesh (Novus Scientific AB, Uppsala -- Sweden) for the prevention of...


04 Dec, 2018, 06:16 GMT Juntendo University Research: Omega-3 Fatty Acids Suppress Allergic Conjunctivitis Symptoms

Researchers at Juntendo University report in the FASEB Journal that a diet based on omega-3 fatty acids alleviates allergic conjunctivitis in mice....


04 Dec, 2018, 03:00 GMT Nordic Nanovector: Additional Preclinical Studies With CD37-targeting Radioimmunotherapies for B-cell Malignancies Presented at ASH

Nordic Nanovector ASA (OSE: NANO) notes that two new poster presentations from preclinical studies with CD37-targeting radioimmunotherapies were made ...


03 Dec, 2018, 16:29 GMT Interim Data from the Ongoing HORIZON Trial with Melflufen Presented in an Oral Presentation at the 60th American Society of Hematology Meeting

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Professor Paul G. Richardson presented updated interim data with melflufen (Ygalo®)...


03 Dec, 2018, 15:00 GMT Comprehensive Analyses from Pivotal Phase 3 QuANTUM-R Study Demonstrate Consistent Overall Survival Benefit of Daiichi Sankyo's FLT3 Inhibitor Quizartinib in Patients with Relapsed/Refractory FLT3-ITD AML

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced comprehensive analyses of overall survival from the pivotal QuANTUM-R phase 3...


03 Dec, 2018, 08:27 GMT Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation notes its portfolio company,...


03 Dec, 2018, 08:25 GMT Arix Bioscience plc: Autolus Presents Initial AUTO3 Clinical Data at ASH

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation notes that its portfolio...


03 Dec, 2018, 08:00 GMT Michelson Diagnostics: Imaging Reveals Changes in Blood Vessel Growth in Deadly Melanoma Skin Cancer

A new clinical study has shown that Dynamic Optical Coherence Tomography imaging of melanomas (D-OCT) reveals changes to the blood vessels that...


03 Dec, 2018, 03:14 GMT Nordic Nanovector: Single Administration Betalutin® is Effective and Well-tolerated in R/R iNHL Patients: 6 Month Follow-up Data Presented at ASH

Overall response rate (ORR) of 61% and complete response (CR) rate of 28% in 74 patients with indolent non-Hodgkin's lymphoma (iNHL) Highly active in ...


03 Dec, 2018, 02:52 GMT BerGenBio Reports 43% Response Rate With Bemcentinib Monotherapy in AXL Positive R/R AML/MDS Patients at ASH

43% CR/CRi/CRp rate with bemcentinib monotherapy reported in AXL biomarker positive R/R AML/MDS patients (6 out of 14) Phase II trial continues in...


02 Dec, 2018, 14:14 GMT Oncopeptides Presents First Interim Data From the Ongoing Combination Trial ANCHOR With Melflufen at the 60th American Society of Hematology Meeting

Overall conclusions The combinations of melflufen and dexamethasone (dex) with either bortezomib or daratumumab in relapsed-refractory multiple...


30 Nov, 2018, 10:00 GMT Altered Microbiome After Caesarean Section Impacts Baby's Immune System, Research by Luxembourg Centre for Systems Biomedicine (LCSB) Finds

Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of...


29 Nov, 2018, 20:04 GMT Micro Interventional Devices, Inc.™ Announces Continued Successful Enrollment in STTAR Trial

Micro Interventional Devices, Inc.™ (MID) announced the continued successful enrollment of patients in STTAR (the Study of Transcatheter Tricuspid...


29 Nov, 2018, 13:00 GMT Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 3 clinical trial evaluating the efficacy...


29 Nov, 2018, 12:01 GMT Alkermes Announces Positive Topline Results From ENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With Schizophrenia

Alkermes plc (Nasdaq: ALKS) today announced positive topline results from ENLIGHTEN-2, a pivotal phase 3 study of ALKS 3831 (olanzapine/samidorphan), ...